NEO: Searching for a cure for Parkinson’s disease
Researchers from the Biotechnology and Biomedicine Institut (IBB) at UAB have discovered a new therapeutical aproximation to Parkinson’s disease, focused on the alpha-synuclein, a protein involved in this and other neurodegenerative disorders, which’s anormal folding produces intracellular agregations that are lethal for the cells. The research carried through by IBB has allowed to identify 6 molecules which aggregate to alpha-synuclein voiding the toxic effect of its abnormal folding.
Author: Institut de Biotecnologia i Biomedicina
